Circulatory system mortality declining in Hodgkin's

Circulatory system mortality declining in hodgkin's
Among patients treated for Hodgkin's lymphoma, long-term excess mortality due to diseases of the circulatory system is expected to continue to decline, according to research published online Feb. 25 in the Journal of Clinical Oncology.

(HealthDay)—Among patients treated for Hodgkin's lymphoma (HL), long-term excess mortality due to diseases of the circulatory system (DCS) is expected to continue to decline, according to research published online Feb. 25 in the Journal of Clinical Oncology.

In an effort to estimate the treatment-related mortality caused by DCS, Sandra Eloranta, of the Karolinska Institute in Stockholm, and colleagues used population-based data for 5,462 patients diagnosed with and treated for HL between 1973 and 2006.

The researchers note that, since the mid-1980s, DCS mortality in HL patients has steadily declined. Patients who were older when diagnosed and men were at higher risk of death due to DCS. After accounting for other causes of death, the number of deaths attributed to HL treatment-related DCS was actually only a small proportion.

"This study shows how the long-term excess DCS mortality experienced by patients with HL in Sweden, diagnosed and treated in the 1990s and early 2000s, is expected to further decrease compared with that of patients diagnosed in earlier years. A similar, but stronger, trend is also observed for the remaining excess HL mortality," the authors write. "The improvements in survival are not likely to be explained by changes in disease characteristics (i.e., a more favorable distribution of in recent years)."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

HIV status doesn't influence Hodgkin's lymphoma outcome

date Oct 11, 2012

(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, ...

Ulcerative colitis, not crohn's, deaths down from 1982

date Jan 21, 2013

(HealthDay)—Over the past 30 years in Denmark, mortality from ulcerative colitis (UC) has decreased, but mortality from Crohn's disease (CD) has remained persistently higher than the general population, ...

Recommended for you

Live imaging reveals how wound healing influences cancer

date 25 minutes ago

Researchers in the United Kingdom and Denmark have studied the "see-through" larvae of zebrafish to reveal how wound healing leads to skin cancer. Live imaging shows neutrophils, the protective inflammatory cells of the body's ...

Protein's impact on colorectal cancer is dappled

date 14 hours ago

Researchers at University of California, San Diego School of Medicine have discovered a cell signaling pathway that appears to exert some control over initiation and progression of colorectal cancer, the ...

Colon cancer: Taking a step back to move forward

date 23 hours ago

Recent Weizmann Institute studies are revealing a complex picture of cancer progression in which certain genes that drive tumor growth in the earlier stages get suppressed in later stages - taking a step ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.